BrightSpring Cost Of Revenue from 2010 to 2024

BTSGU Stock   71.13  1.98  2.86%   
BrightSpring Health Cost Of Revenue yearly trend continues to be comparatively stable with very little volatility. Cost Of Revenue will likely drop to about 6.5 B in 2024. From the period from 2010 to 2024, BrightSpring Health Cost Of Revenue quarterly data regression had r-value of  0.77 and coefficient of variation of  24.27. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
8.5 B
Current Value
6.5 B
Quarterly Volatility
1.3 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BrightSpring Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BrightSpring Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 216.4 M, Interest Expense of 237.2 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.0 or PTB Ratio of 3.38. BrightSpring financial statements analysis is a perfect complement when working with BrightSpring Health Valuation or Volatility modules.
  
Check out the analysis of BrightSpring Health Correlation against competitors.

Latest BrightSpring Health's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of BrightSpring Health Services, over the last few years. Cost of Revenue is found on BrightSpring Health income statement and represents the costs associated with goods and services BrightSpring Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is BrightSpring Health's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BrightSpring Health's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

BrightSpring Cost Of Revenue Regression Statistics

Arithmetic Mean5,303,646,780
Geometric Mean5,180,763,339
Coefficient Of Variation24.27
Mean Deviation1,029,350,373
Median4,531,634,000
Standard Deviation1,287,258,644
Sample Variance1657034.8T
Range4B
R-Value0.77
Mean Square Error721861.6T
R-Squared0.60
Significance0.0008
Slope222,118,749
Total Sum of Squares23198487.4T

BrightSpring Cost Of Revenue History

20246.5 B
20238.5 B
20227.4 B
20216.4 B
20205.4 B

About BrightSpring Health Financial Statements

BrightSpring Health shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although BrightSpring Health investors may analyze each financial statement separately, they are all interrelated. The changes in BrightSpring Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on BrightSpring Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue8.5 B6.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BrightSpring Stock Analysis

When running BrightSpring Health's price analysis, check to measure BrightSpring Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightSpring Health is operating at the current time. Most of BrightSpring Health's value examination focuses on studying past and present price action to predict the probability of BrightSpring Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightSpring Health's price. Additionally, you may evaluate how the addition of BrightSpring Health to your portfolios can decrease your overall portfolio volatility.